We guide our patients on how to administer semaglutide weight loss injections safely and effectively
Drug type Dual GIP/GLP-1 receptor agonist Active ingredient Tirzepatide (same as Zepbound/Mounjaro) FDA status Not FDA-approved (compounded) 2026 legality Narrow 503A patient-specific only Typical cost ~$125$449/mo, self-pay Looking for a prescription provider route
Is the insulated container inside in good condition
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in key GLP-1 signaling pathwaysincluding GLP1R sensitivity and GIPR functionthat may help provide context for your individual dose tolerance
For instance, Wegovy has been associated with increased heart rate and the potential for gallbladder-related issues, such as gallstones
Additionally, the Merck application does not disclose that a peptide-based melanocortin agonist may be administered by an intranasal route and a PDE-5 inhibitor administered by an oral route, or that the agents may be sequentially administered at timed intervals to obtain optimal results
